Annual Meeting 2015

Risk Management in Early Phase Clinical Trials

Thursday 29th October, 12.30 – 17.00

Academy of Medical Sciences, London

We are pleased to include below the presentations from this year’s AHPPI Annual Meeting.

Please click the links in or near each speaker’s name to download and open a PDF of the presentation.


12:30 Arrival
13.00 Introduction to the AHPPI Annual Meeting Prof Keith Wesnes, AHPPI Chair
13.15 Risk Management in a CRO Phase I Unit Dr John Lambert, PAREXEL
13.50 Risk Management for Early Trials in biologicals Dr Richard FitzGerald, Royal Liverpool University Hospital
14:20 Tea/Coffee & Networking
14:55 Cardiac Safety – the industry and regulatory perspectives Dr Boaz Mendzelevski, BioClinica and Dr Krishna Prasad, MHRA
15:35 Use of a novel risk rating system in clinical trials Dr Brian Leaker, Respiratory Clinical Trials Ltd, Queen Anne Street Medical Centre
16:05 Introduction to EUFEMED & European Training Course in Human Pharmacology Dr Jörg Täubel, EUFEMED
16:20 Update on the implementation of the new EU Clinical Trial Regulation’s transparency rules for early phase trials Dr Ulrike Lorch, AHPPI Chair-elect
16:40 AHPPI Updates Dr Peter Dewland, AHPPI Treasurer, Dr Tim Hardman & Steffan Stringer, AHPPI Committee (slides, speaker notes)
17:00 Closing Remarks followed by drinks reception Prof Keith Wesnes, AHPPI Chair

We were delighted to be sponsored by BioKinetic Europe and Niche Science & Technology for this year’s programme.

logo-2 logo

Comments are closed.